Hikma Pharmaceuticals Plc’s Core operating profit increase by 15% in H1 2020; stocks surge over 10%

Hikma Pharmaceuticals Plc (LON: HIK) has released its results for the six months ended 30 June 2020.

  • Core revenue of the company improved by 9 per cent $1,132 million in H1 2020 as compared to $1,043 million in H1 2019, the rise in revenue reflected growth in all three businesses.
  • Core operating profit of the company improved by 15 per cent (AER basis) to $284 million, from $246 million in the same period last year, driven by a strong performance in Injectables.
  • The company reported a significant 56 per cent increase in cash flow from operating activities to $292 million as compared to $187 million in H1 2019.
  • On 7August 2020, at the time of writing, GMT 11:51 AM, HIK shares were trading at GBX 2,385.00, up by 228 points or 10.57% against the previous day closing price.

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is not authorised or regulated by the Financial Conduct Authority to provide regulated advice. The purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. The Content is guidance about the different types of investments that are available and sets out general principles to continue before making investment decisions. Kalkine Media is neither authorised nor qualified to provide regulated investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from an appropriately authorised and/or qualified financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.